跳至主要内容
临床试验/ACTRN12613000411741
ACTRN12613000411741尚未招募未知

Efficacy and safety of chloroquine for the treatment of Plasmodium vivax malaria in Teyarett District in Nouakchott and in the city of d'Atar (Adra Province) in Mauritania.

Ministry of Health of Mauritania0 个研究点目标入组 180 人开始时间: 2013年4月15日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
6 Months 至 o limit(—)
性别
All

入选标准

  • age 6 months and older
  • mono-infection with P vivax detected by microscopy
  • asexual parasite count greater than 250 per microliter
  • axillary temperature greater than 37.5 degrees Celsius or history of fever during the 48 hours before recruitment
  • able to swallow oral medication
  • able and willing to comply with the protocol and schedule of assessments
  • informed consent

排除标准

  • clinical condition due to vivax malaria (coma, respiratory distress syndrome or severe anaemia) requiring hospitalisation
  • severe malnutrition according to WHO child growth standards
  • febrile condition due to diseases other than malaria (e.g. measles, acute lower respiratory tract infection, severe diarrhoea with dehydration) or other known underlying chronic or severe disease
  • history of hypersensitivity reactions to any medicine tested

研究者

发起方
Ministry of Health of Mauritania

相似试验